Koenigsegg has one problem that no other carmaker has complained about. The hypercar manufacturer won't solve it before 2026.

Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India's Piramal Pharma, online news portal Moneycontrol reported on Thursday, citing sources. The U.S.-based firm could ...